Reference
Qin S, et al. Cost-Effectiveness of Atezolizumab Plus Chemotherapy as First-Line Therapy for Metastatic Urothelial Cancer. . Advances in Therapy : 12 May 2021. Available from: URL: http://doi.org/10.1007/s12325-021-01785-9
Rights and permissions
About this article
Cite this article
Atezolizumab + chemotherapy not cost effective for metastatic urothelial cancer. PharmacoEcon Outcomes News 879, 4 (2021). https://doi.org/10.1007/s40274-021-7727-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7727-7